PMID: 2446915Nov 1, 1987

The management of myelomatosis

European Journal of Haematology
D A GALTON, F Brito-Babapulle


No abstract listed.


Mar 29, 1975·Lancet·T C StampP G Walker
Jun 9, 1979·British Medical Journal·W J BensonD Crowther
Dec 1, 1977·Cancer·R AlexanianJ Weick
Jan 1, 1978·Acta Medica Scandinavica·L Unander-ScharinO Zettervall
May 1, 1975·British Journal of Cancer·J F Smyth, K R Harrap
Apr 2, 1987·The New England Journal of Medicine·A S SpiersM J O'Connell
May 1, 1985·British Journal of Cancer·R C PercivalJ A Kanis
Feb 1, 1986·Scandinavian Journal of Haematology·S TuraM Gobbi
Aug 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B G DurieJ J Costanzi
Jan 1, 1986·Acta Medica Scandinavica·G GahrtonP Ljungman
May 1, 1987·British Journal of Haematology·P J SelbyJ S Malpas
May 1, 1986·Arthritis and Rheumatism·M D Benson
Sep 1, 1986·Annals of Internal Medicine·M H GreeneJ D Boice
Jan 1, 1985·Cancer Chemotherapy and Pharmacology·A R BelchL W Brox
Jul 1, 1985·Scandinavian Journal of Haematology·O P Hansen, D A GALTON
Mar 1, 1986·The American Journal of Medicine·K Fielder, B G Durie
Jan 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J S TobiasJ I Nathan
May 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J J CostanziR J Spiegel
Feb 1, 1966·Acta Medica Scandinavica·U AxelssonJ Hällén
Sep 1, 1974·Cancer·B DrewinkoR Alexanian
May 8, 1971·British Medical Journal·D Bergsagel
Jan 1, 1972·The American Journal of Medicine·B R MeyersJ A Axelrod
Feb 1, 1966·Acta Radiologica: Therapy, Physics, Biology·T Norin
Jul 12, 1980·Lancet·B G DurieS E Salmon
Jan 7, 1984·Lancet·J A Kanis
Jun 5, 1980·The New England Journal of Medicine·G G Glenner
Nov 1, 1984·British Journal of Haematology·A Y RostomA Folkes
Jan 1, 1982·Acta Haematologica·E F OSSERMANR Storb
May 1, 1983·British Journal of Haematology·A D PatersonR G Russell
Jan 1, 1981·Metabolic Bone Disease & Related Research·H Fleisch
Jun 28, 1984·The New England Journal of Medicine·G R MundyT J Martin
Dec 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A S SpiersM B Bishop
Feb 7, 1980·The New England Journal of Medicine·E S SirisR E Canfield
May 24, 1984·The New England Journal of Medicine·B BarlogieR Alexanian
Aug 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Bergsagel
Jul 15, 1983·International Journal of Cancer. Journal International Du Cancer·J CuzickR Doll
Jun 12, 1980·The New England Journal of Medicine·R A Kyle, P R Greipp
Mar 1, 1953·Southern Medical Journal·R W RUNDLESE V COONRAD
Dec 1, 1954·Annals of Internal Medicine·H H ZINNEMAN, W H HALL
Apr 24, 1958·Annals of the New York Academy of Sciences·N BLOKHINN MERKULOVA
Apr 4, 1964·British Medical Journal·J WALDENSTROEM
Jun 27, 1964·British Medical Journal·D E SPEEDA SWAN
Aug 1, 1955·American Journal of Clinical Pathology·C P CARSONJ D MALTBY
Oct 27, 1951·Journal of the American Medical Association·W F LUTTGENS, E D BAYRD
Feb 1, 1949·The American Journal of Medicine·W S ADAMSJ S LAWRENCE
Jan 18, 1947·Journal of the American Medical Association·E D BAYRD, F J HECK


Jun 15, 1991·Cancer·N C CherngD Solanki

Related Concepts

Antineoplastic Chemotherapy Protocols
Bacterial Infections
Clinical Trials
Combined Modality Therapy
Kidney Failure, Chronic
Multiple Myeloma
Neoplasm Recurrence, Local

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Comprehensive Therapy
R M Rowan
Ugeskrift for laeger
H Friis, O Porsman
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
© 2021 Meta ULC. All rights reserved